Second ‘French Tech Tour Healthcare Israel’

24 May 2017
research_big

For the second year running, Business France, the French public investment bank Bpifrance and the Medicen Paris Region healthcare business cluster are staging the French Tech Tour Healthcare Israel, a tailor-made program that immerses French healthcare start-ups in Israel’s tech and healthcare ecosystem.

Its aim is to help these young businesses confirm their development potential, create technology partnerships and to give them the experience they need to reach in one of the world’s most innovative markets.

For this second tour, seven start-ups specialized in medical devices, biotech and ehealth were selected by a judging panel of French and Israeli healthcare experts. They will receive dedicated support for a period of three months, including a one-week immersion workshop in Tel Aviv, Israel, from May 20 to 25, 2017.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical